Washington / DC / San Francisco / Fischl / Volberding / Koch / Jacobson / Moss / Chicago / /
Company
National Academy Press / Fleming / The University of Chicago Press / AIDS Clinical Trials Group / /
Event
FDA Phase / /
Facility
LABORATORY SCIENCE OF HIV Table / Infectious Diseases Beth Israel Medical Center / AIDSrelated complex / San Francisco General Hospital / Institute of Medicine / /
IndustryTerm
treatment of HIV / important applications / treatment for HIV / AIDS therapies / literature search / experimental protocols / /
MedicalCondition
HIV infection / Kagan J. Clinical Infectious Diseases / HIV / opportunistic infections / disease / strain / Acquired immune deficiency syndrome / fundamental disease / acquired immunodeficiency syndrome / clinical disease / Marker Validation disease / AIDS / hypersensitivity / HIV/AIDS epidemic / infection / Positive-Outcome Studies HIV disease / early HIV infection / HIV disease / AIDS-related complex / /
University of Chicago Press / The University of Chicago / Division of Infectious Diseases Beth Israel Medical Center New York / Markers Subcommittee / Surrogate / /
Person
Donna Mildvan / Arch Intem Med / Ann Intern Med / Ann Intem Med / /
Position
representative / General / et al.* Chief / /
Product
zidovudine / didanosine / Clinical Efficacy If / /
1998 CONFERENCE ON THE LABORATORY SCIENCE OF HIV AN APPROACH TO THE VALIDATION OF MARKERS FOR USE IN AIDS CLINICAL TRIALS Donna Mildvan, M.D., et al.* Chief, Division of Infectious Diseases